Personalis, Inc. (PSNL): Total Liabilities
$72.98M
As of 2025-12-31
$76.97M
As of 2026-06-30
-0.7%
3-year compound annual growth
+7.9%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $72.98M | +8.4% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $67.31M | -29.6% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $95.66M | +28.3% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $74.56M | -13.5% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $86.23M | +72.8% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $49.90M | -1.4% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $50.60M | -13.7% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $58.65M | n/a | 2020-03-25, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Personalis, Inc. (PSNL) | 2025-12-31 | $72.98M | +8.4% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $344.15M | -28.3% |
| CapForce Inc. (CFOR) | 2025-12-31 | $6.20M | +149.7% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $152.55M | +13.6% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $106.81M | +17.6% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
Compare PSNL, XGN, BDSX, GRAL side by side · Screen every company in Services-Medical Laboratories ↗